Stanford researchers found that stem cells transplanted into the brains of rats and mice navigate toward areas damaged by stroke
O Jun. 4, 2007, researchers from the Stanford University School of Medicine announced they had illuminated the path…
-
-
Dr. Bagby retired as OHSU director and Brian Druker, MD was named his successor
On May 21, 2007, Oregon Health & Science University (OHSU) announced that Grover Bagby, M.D., after 15 years…
-
The University of New Mexico Cancer Center broke ground on new state-of-the-art cancer treatment and research facility
On May 15, 2007, the University of New Mexico Cancer Center broke ground on new state-of-the-art cancer treatment…
-
National Breast and Cervical Cancer Act allowed states federal waivers to spend a greater share of funds on underserved women
On Apr. 20, 2007, President Bush signed critical legislation into law today to expand a successful program that…
-
OHSU-Led alcohol research consortium received $24 million NIAAA grant
On Mar. 20, 2007, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced a five-year, $24 million…
-
OHSU received $40 million donation from an anonymous donor
On Feb. 8, 2007, Oregon Health & Science University (OHSU) and the OHSU Foundation announced the largest outright gift…
-
CDC published Interim Pre-pandemic Planning Guidance Strategy for Pandemic Influenza Mitigation in the U.S.
On Feb. 1, 2007, the Centers for Disease Control and Prevention (CDC) released its long-awaited disease containment strategy…
-
Eli Lilly completed its acquisition of ICOS Corp for $23 billion
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
-
Phase III clinical trial showed patients treated with arsenic trioxide had better overall survival than patients who received chemotherapy alone
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
-
FDA licensed the refrigerator formulation of FluMist
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
-
Biotechnology | CDC | Influenza | Therapeutics | Vaccine
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
-
Virginia Tech Carilion School of Medicine and Research Institute was founded
On Jan. 3, 2007, Virginia Tech President Charles W. Steger, then Carilion Clinic President and CEO Edward G….
-
Jordan Tang led a team of OMRF scientists that identified and cloned the enzyme believed to cause Alzheimer’s disease
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
-
The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
-
Vanderbilt Center for Neuroscience Drug Discovery was founded
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
-
The St Jude LIFE study on long-term effects of cancer and its treatment launched
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
-
The Cancer Prevention and Research Institute of Texas was founded
In 2007, Texans voted to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest…
-
Texas Biomed geneticists announced discovery that a particular gene, VNN1, plays a major role in the regulation of HDL cholesterol levels
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
-
The Center for Clinical and Translational Research was founded at Virginia Commonwealth University
In 2007, the Center for Clinical and Translational Research (CCTR) was founded at Virginia Commonwealth University to enhance…
-
R Paul Robertson received two NIDDK grants totaling to improve islet transplantation
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
-
Richard Nakamura, PhD, became the first Asian American scientific director of the National Institute of Mental Health
In 2007, Richard Nakamura, Ph.D., became the first Asian American scientific director of the National Institute of Mental…
-
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
-
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
-
Lethal infection of K18-hACE2 mice infected with Severe Acute Respiratory Syndrome Coronavirus published
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…
-
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease
In 2007, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy…
-
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
-
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
-
The FDA approved Glivec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
-
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
